Molekule for Allergic Rhinitis/Asthma
| Status: | Terminated |
|---|---|
| Conditions: | Allergy, Asthma, Ocular |
| Therapuetic Areas: | Ophthalmology, Otolaryngology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 2/7/2019 |
| Start Date: | July 13, 2018 |
| End Date: | January 31, 2019 |
Exposure to airborne allergens and pollutants is linked to symptom severity of allergies,
asthma and other respiratory problems. In this study an air purifier using
photo-electrochemical oxidation technology (PECO) will be used in the home environment of
study participants. The investigator will assess the reduction of symptoms from allergic
rhinitis/conjunctivitis and asthma.
asthma and other respiratory problems. In this study an air purifier using
photo-electrochemical oxidation technology (PECO) will be used in the home environment of
study participants. The investigator will assess the reduction of symptoms from allergic
rhinitis/conjunctivitis and asthma.
The purpose of this study is to assess the efficacy of the portable PECO air purifier in
reducing symptoms from allergic rhinitis and asthma. Using a randomized, double blinded
placebo, controlled trial we will be then able to assess if there are any changes after the
use of the PECO air purifier after completing an initial baseline survey & comparing to the
exit survey. This is a double-blind study, which means that neither the participant nor the
investigator knows which device is being used until after the trial is over.
reducing symptoms from allergic rhinitis and asthma. Using a randomized, double blinded
placebo, controlled trial we will be then able to assess if there are any changes after the
use of the PECO air purifier after completing an initial baseline survey & comparing to the
exit survey. This is a double-blind study, which means that neither the participant nor the
investigator knows which device is being used until after the trial is over.
Inclusion Criteria:
1. Chronic allergic rhinitis and/or conjunctivitis by history
2. History of adult asthma requiring medications now or in the past
3. Age ≥18
4. CARAT score less than 24
Exclusion Criteria:
1. Participant is <18 years-old
2. Use of systemic corticosteroids within 14 days of study initiation
3. Treatment with biologic agents or allergen immunotherapy
4. Treatment with other immunomodulators (cyclosporine, azathioprine, hydroxychloroquine,
etc)
5. Sensitive to fan sound or blue/purple light at night time
We found this trial at
1
site
Click here to add this to my saved trials
